$ISR Headlines Wednesday's biggest gaining and
Post# of 102773
Posted On: 01/26/2015 12:02:33 PM
$ISR Headlines
Wednesday's biggest gaining and declining stocks 3:44 p.m. Aug. 19, 2009 - MarketWatch
IsoRay up premarket on brain cancer results 9:24 a.m. Dec. 1, 2014 - Seeking Alpha
Accuray CyberKnife M6 System Now Available in Manhattan - Analyst Blog 6:05 p.m. Nov. 19, 2014 - Zacks.com
10-Q: ISORAY, INC. 4:06 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
IsoRay jumps on report of single surgery 11:54 a.m. Oct. 7, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 10:02 a.m. Oct. 7, 2014 - TheStreet.com
Ad Comm smacks down Sonacare's HIFU device for prostate cancer 12:53 p.m. Oct. 3, 2014 - Seeking Alpha
10-K: ISORAY, INC. 3:44 p.m. Sept. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Top Swing Trade Ideas for Thursday, Aug. 21: Alcoa, Sodastream, More 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Why IsoRay (ISR) Stock Is Spiking Today 10:41 a.m. July 14, 2014 - TheStreet.com
First Cesium-131 seed implanted 8:02 a.m. July 14, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 9:38 a.m. June 24, 2014 - TheStreet.com
First patient treated with Cesitrex 8:24 a.m. June 24, 2014 - Seeking Alpha
More on IsoRay fiscal Q3 results 9:16 a.m. May 16, 2014 - Seeking Alpha
10-Q: ISORAY, INC. 4:18 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why IsoRay (ISR) Stock Is Surging Today 10:10 a.m. May 12, 2014 - TheStreet.com
IsoRay's Liquid Cesium-131 receives final OK for use in brain cancer 9:02 a.m. May 12, 2014 - Seeking Alpha
IsoRay (ISR) Is Today's Dead Cat Bounce Stock 8:46 a.m. May 12, 2014 - TheStreet.com
Perilous Reversal Watch: IsoRay (ISR) 8:49 a.m. May 8, 2014 - TheStreet.com
Irrational exuberance is alive and well with IsoRay 9:33 a.m. April 30, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 9:30 a.m. April 30, 2014 - TheStreet.com
UPMC Study Reports IsoRay's Cesium-131 Prostate Treatment Provides Strong Cancer Control With Lower Side Effects, Providing Men Improved Quality of Life 8:16 a.m. Jan. 20, 2015 - Marketwired
IsoRay's Cesium-131 Therapy Takes Center Stage at Russia's Neftyanik Hospital a Center of Excellence Providing Cutting Edge Cancer Treatments 8:15 a.m. Jan. 13, 2015 - Marketwired
IsoRay Ranked 5th Highest Share Price Percentage Gainer (192%) in 2014 Among 2417 Companies Listed on the NYSE Group 8:15 a.m. Jan. 12, 2015 - Marketwired
IsoRay's Cesium-131 Used in World's First Veterinary Implant in a Horse With Cancer 8:03 a.m. Dec. 8, 2014 - Marketwired
Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma 8:50 a.m. Dec. 4, 2014 - PR Newswire - PRF
IsoRay's Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed 8:20 a.m. Dec. 1, 2014 - ACCESSWIRE
IsoRays Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed 8:01 a.m. Dec. 1, 2014 - eTeligis
IsoRay, Inc. Reports First Quarter Results 8:01 a.m. Nov. 17, 2014 - eTeligis
IsoRay Celebrates 10 Year Success Story With the First Prostate Patient Treated With Cesium-131 7:31 a.m. Oct. 29, 2014 - ACCESSWIRE
IsoRay Celebrates 10 Year Success Story With the First Prostate Patient Treated With Cesium-131 7:17 a.m. Oct. 29, 2014 - eTeligis
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 8:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer 7:16 a.m. Oct. 7, 2014 - Marketwire
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer 7:06 a.m. Oct. 7, 2014 - eTeligis
IsoRay, Inc. Reports Fiscal Year 2014 Results 7:46 a.m. Sept. 30, 2014 - Marketwire
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO) 7:31 a.m. Sept. 9, 2014 - Marketwire
ISORAYS CESIUM-131 CANCER TREATMENT PRODUCTS AND METHODS TO BE FEATURED IN ORAL PRESENTATIONS BY INDUSTRY LEADERS DURING THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY CONVENTION (ASTRO) 7:17 a.m. Sept. 9, 2014 - eTeligis
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 8:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery 7:33 a.m. Aug. 5, 2014 - Marketwire
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery 7:16 a.m. Aug. 5, 2014 - eTeligis
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 7:40 a.m. July 31, 2014 - PR Newswire - PRF
Wednesday's biggest gaining and declining stocks 3:44 p.m. Aug. 19, 2009 - MarketWatch
IsoRay up premarket on brain cancer results 9:24 a.m. Dec. 1, 2014 - Seeking Alpha
Accuray CyberKnife M6 System Now Available in Manhattan - Analyst Blog 6:05 p.m. Nov. 19, 2014 - Zacks.com
10-Q: ISORAY, INC. 4:06 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
IsoRay jumps on report of single surgery 11:54 a.m. Oct. 7, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 10:02 a.m. Oct. 7, 2014 - TheStreet.com
Ad Comm smacks down Sonacare's HIFU device for prostate cancer 12:53 p.m. Oct. 3, 2014 - Seeking Alpha
10-K: ISORAY, INC. 3:44 p.m. Sept. 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Top Swing Trade Ideas for Thursday, Aug. 21: Alcoa, Sodastream, More 9:45 a.m. Aug. 21, 2014 - TheStreet.com
Why IsoRay (ISR) Stock Is Spiking Today 10:41 a.m. July 14, 2014 - TheStreet.com
First Cesium-131 seed implanted 8:02 a.m. July 14, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 9:38 a.m. June 24, 2014 - TheStreet.com
First patient treated with Cesitrex 8:24 a.m. June 24, 2014 - Seeking Alpha
More on IsoRay fiscal Q3 results 9:16 a.m. May 16, 2014 - Seeking Alpha
10-Q: ISORAY, INC. 4:18 p.m. May 15, 2014 - Edgar Online - (EDG = 10Q, 10K)
Why IsoRay (ISR) Stock Is Surging Today 10:10 a.m. May 12, 2014 - TheStreet.com
IsoRay's Liquid Cesium-131 receives final OK for use in brain cancer 9:02 a.m. May 12, 2014 - Seeking Alpha
IsoRay (ISR) Is Today's Dead Cat Bounce Stock 8:46 a.m. May 12, 2014 - TheStreet.com
Perilous Reversal Watch: IsoRay (ISR) 8:49 a.m. May 8, 2014 - TheStreet.com
Irrational exuberance is alive and well with IsoRay 9:33 a.m. April 30, 2014 - Seeking Alpha
Why IsoRay (ISR) Stock Is Surging Today 9:30 a.m. April 30, 2014 - TheStreet.com
UPMC Study Reports IsoRay's Cesium-131 Prostate Treatment Provides Strong Cancer Control With Lower Side Effects, Providing Men Improved Quality of Life 8:16 a.m. Jan. 20, 2015 - Marketwired
IsoRay's Cesium-131 Therapy Takes Center Stage at Russia's Neftyanik Hospital a Center of Excellence Providing Cutting Edge Cancer Treatments 8:15 a.m. Jan. 13, 2015 - Marketwired
IsoRay Ranked 5th Highest Share Price Percentage Gainer (192%) in 2014 Among 2417 Companies Listed on the NYSE Group 8:15 a.m. Jan. 12, 2015 - Marketwired
IsoRay's Cesium-131 Used in World's First Veterinary Implant in a Horse With Cancer 8:03 a.m. Dec. 8, 2014 - Marketwired
Biotech Stocks Technical Coverage - OPKO Health, IsoRay, Nanosphere, Amicus Therapeutics, and Isis Pharma 8:50 a.m. Dec. 4, 2014 - PR Newswire - PRF
IsoRay's Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed 8:20 a.m. Dec. 1, 2014 - ACCESSWIRE
IsoRays Cesium-131 Therapy Stops Brain Cancers from Recurring in Treated Locations Where Previous Conventional Treatments Failed 8:01 a.m. Dec. 1, 2014 - eTeligis
IsoRay, Inc. Reports First Quarter Results 8:01 a.m. Nov. 17, 2014 - eTeligis
IsoRay Celebrates 10 Year Success Story With the First Prostate Patient Treated With Cesium-131 7:31 a.m. Oct. 29, 2014 - ACCESSWIRE
IsoRay Celebrates 10 Year Success Story With the First Prostate Patient Treated With Cesium-131 7:17 a.m. Oct. 29, 2014 - eTeligis
Pre-market Biotech Picks - Gilead Sciences, MannKind, IsoRay, Orexigen Therapeutics, and Sunesis Pharma 8:00 a.m. Oct. 14, 2014 - PR Newswire - PRF
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer 7:16 a.m. Oct. 7, 2014 - Marketwire
Isoray Announces Early Success for Young Peruvian Girl Utilizing Cesium-131 in First Stereotactic Implant for Inoperable Brain Cancer 7:06 a.m. Oct. 7, 2014 - eTeligis
IsoRay, Inc. Reports Fiscal Year 2014 Results 7:46 a.m. Sept. 30, 2014 - Marketwire
IsoRay's Cesium-131 Cancer Treatment Products and Methods to Be Featured in Oral Presentations by Industry Leaders During the American Society for Radiation Oncology Convention (ASTRO) 7:31 a.m. Sept. 9, 2014 - Marketwire
ISORAYS CESIUM-131 CANCER TREATMENT PRODUCTS AND METHODS TO BE FEATURED IN ORAL PRESENTATIONS BY INDUSTRY LEADERS DURING THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY CONVENTION (ASTRO) 7:17 a.m. Sept. 9, 2014 - eTeligis
Technical Coverage on Biotech Equities - Galena Biopharma, Gilead Sciences, MannKind, Orexigen Therapeutics, and IsoRay 8:05 a.m. Sept. 3, 2014 - PR Newswire - PRF
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery 7:33 a.m. Aug. 5, 2014 - Marketwire
IsoRay's Cesium-131 Isotope Produces Excellent Results in Treating Metastatic Brain Cancer as Published in the Journal of Neurosurgery 7:16 a.m. Aug. 5, 2014 - eTeligis
Market Momentum on Biotech Stocks -- IsoRay, Neurocrine Biosciences, OPKO Health, Orexigen Therapeutics, and Gilead Sciences 7:40 a.m. July 31, 2014 - PR Newswire - PRF
(0)
(0)